Dynavox Group AB (publ) (STO:DYVOX)
Sweden · Delayed Price · Currency is SEK 98.10
-2.40 (-2.39%)
At close: Oct 31, 2025
Dynavox Group AB Revenue
Dynavox Group AB had revenue of 606.00M SEK in the quarter ending September 30, 2025, with 25.47% growth. This brings the company's revenue in the last twelve months to 2.38B, up 27.74% year-over-year. In the year 2024, Dynavox Group AB had annual revenue of 1.97B with 22.24% growth.
Revenue (ttm)
2.38B
Revenue Growth
+27.74%
P/S Ratio
4.41
Revenue / Employee
2.36M
Employees
855
Market Cap
10.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.97B | 358.80M | 22.24% |
| Dec 31, 2023 | 1.61B | 396.90M | 32.63% |
| Dec 31, 2022 | 1.22B | 344.80M | 39.56% |
| Dec 31, 2021 | 871.60M | -23.60M | -2.64% |
| Dec 31, 2020 | 895.20M | -13.60M | -1.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.22B |
| Elekta AB | 17.84B |
| Asker Healthcare Group AB | 15.88B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |